FSRH Clinical Guideline: Progestogen-only Implant (February 2021, Amended July 2023)
... during extended use of the etonogestrel implant .................................. 5 7.2 What drug interactions are important to consider? ...
FSRH Clinical Guideline: Progestogen-only Pills (August 2022, Amended July 2023)
... 11 9.5 Drug interactions ...
FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended July 2023)
... 15 10 Are there Any Factors that Would Affect the Efficacy of Progestogen-only Injectables? 16 10.1 Drug interactions 16 10.2 Weight 16 11 Other Considerations 17 11.1 Return of fertility 17 11.2 Emergency ...
FSRH Clinical Guideline: Intrauterine contraception (March 2023, Amended July 2023)
... imaging NICE National Institute for Health and Care Excellence NSAID nonsteroidal anti-inflammatory drug OR odds ratio PI Pearl Index PID pelvic inflammatory disease POP PoTS progestogen-only pill postural ...
FSRH Clinical Guideline: Emergency Contraception (March 2017, amended July 2023)
... 15 10 What Drug Interactions are Relevant to Use of EC? ........................................................... ...
FSRH Clinical Guideline: Contraception for Women Aged over 40 Years (August 2017, amended July 2023)
... or otherwise – a woman may be using to address her perimenopausal symptoms and consider potential drug interactions when prescribing contraception. 5 Suitability of Contraceptive Methods for Women Over ...
FSRH Clinical Guideline: Combined Hormonal Contraception (January 2019, Amended July 2023)
... 18 7.2.2 Is contraceptive effectiveness of CHC affected by bariatric surgery? 18 7.2.3 What drug interactions are important to consider in relation to CHC? 19 7.2.4 Severe diarrhoea or vomiting 21 ...
FSRH CEU Guidance: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception (February 2023)
... cookies are set via our cookie settings page. I'm OK with that Let me choose FSRH CEU Guidance: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception (February 2023) Published ...
FSRH CEU new product review: Drovelis® estetrol/drospirenone combined oral contraceptive (October 2022)
... European/Russian phase III study[4], 9.1% discontinued because of apparent side effects of E4/DRSP. Drug interaction Key information: As with other CHC, the contraceptive effectiveness of E4/DRSP could be ...
FSRH Service Standards for Clinical Risk Management in SRH - October 2022
... provided with supply of medicine 5.4 Inadequate medical history leading to inability to prevent drug interaction and anaphylaxis 5.5 Lack of security to prevent theft of drugs and prescription ...